U.S. Pharma Stock News

NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Assessing Cognex (CGNX) Valuation After Strong 1 Year Returns And A High P/E Multiple

Why Cognex may be on your radar now Cognex (CGNX) has drawn attention after a mixed stretch in the share price, with a small pullback over the past week following gains over the past month and the past 3 months. See our latest analysis for Cognex. At a share price of US$48.77, Cognex has given investors a 36.8% 90 day share price return and a 62.47% 1 year total shareholder return, which signals building momentum despite the recent 1 day and 7 day pullback. If Cognex's recent move has you...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Corvus Trials Progress And Cash Raise Reframe Soquelitinib Risk Reward Profile

Corvus Pharmaceuticals has moved its lead candidate, soquelitinib, into late-stage Phase 3 and Phase 2 trials across several indications. The company raised $189 million in a follow-on offering, which it says extends its cash runway into 2028. Corvus Pharmaceuticals (NasdaqGM:CRVS) is drawing attention after pushing soquelitinib into more advanced clinical trials while securing fresh capital to support the work. The stock trades at $16.01, with very large 3-year and 1-year returns, and a...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

Assessing First Merchants (FRME) Valuation After Recent Share Price Weakness

If you are wondering whether First Merchants at around US$36.55 is offering good value today, you are not alone. This article will walk through what the current price may be implying. The stock has seen mixed returns, with a 5.2% decline over the last 7 days and a 12.5% decline over the last 30 days, while the 3 year return sits at 11.9% and the 1 year return at a 2.9% decline. Recent trading moves have put more attention on how investors are pricing regional banks like First Merchants and...
NYSE:NUE
NYSE:NUEMetals and Mining

Nucor Commercial Chief Retirement Puts Succession And Pricing Discipline In Focus

Nucor Corporation (NYSE:NUE) announced that Executive Vice President of Commercial, Daniel R. Needham, plans to retire after a long tenure with the company. His retirement marks the departure of a senior leader who has held a key commercial role within Nucor. The company has described this as a planned transition, giving stakeholders time to assess potential implications for commercial operations and leadership continuity. Nucor, a major US steel producer, operates at the center of sectors...
NYSE:ATEN
NYSE:ATENSoftware

A Look At A10 Networks (ATEN) Valuation After Fresh Optimism On AI Security Demand

A10 Networks (ATEN) is back in focus after a research firm highlighted what it sees as strong demand for the company’s network security products tied to AI infrastructure, surging traffic, and expanding customer data centers. See our latest analysis for A10 Networks. The latest AI related enthusiasm comes after a period of steady gains, with the share price at US$21.06 and a 90 day share price return of 16.23%, while the 5 year total shareholder return of 125.84% points to sustained investor...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback

If you are trying to figure out whether Precigen's current share price reflects its underlying value, you are not alone. This article is built to walk you through that question step by step. The stock last closed at US$3.28, with returns of 88.5% over 1 year and 203.7% over 3 years, but also a 29.6% decline over 30 days and a 23.4% decline year to date. These moves can change how investors think about both potential and risk. Recent company updates and sector news have kept Precigen on many...
NYSE:FUN
NYSE:FUNHospitality

Is It Time To Reassess Six Flags Entertainment (FUN) After Its Prolonged Share Price Slump?

If you are wondering whether Six Flags Entertainment is a bargain or a value trap at around US$15.57 per share, this article walks through what the numbers actually say about the stock's current price. The share price is roughly flat year to date with a 0.5% return, but the stock has seen a 11.1% decline over the last 7 days, a 13.8% decline over the last 30 days, and a 55.6% decline over the past year, along with a 64.0% and 67.0% decline over the last 3 and 5 years respectively, which is...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

A Look At Sirius XM (SIRI) Valuation After Recent Debt Refinancing And Lower Near Term Obligations

Debt refinancing puts Sirius XM Holdings (SIRI) capital structure in focus Sirius XM Holdings (SIRI) recently refinanced part of its balance sheet by issuing new 2032 notes and using the proceeds to retire about US$498.9 million of 3.125% Senior Notes due 2026. The company also satisfied and discharged the remaining 2026 note obligations by depositing US treasuries with the trustee, reducing near-term debt commitments and giving investors fresh information to assess its capital...
NYSE:HG
NYSE:HGInsurance

Do Hamilton’s New Underwriting Leaders Reshape HG’s Strategic Edge In Specialty Reinsurance?

Hamilton Insurance Group recently reshaped leadership at its London-based Hamilton Global Specialty unit, appointing long-time executive Sinead Cormican as Chief Underwriting Officer while she continues as Active Underwriter of Syndicate 4000, and expanding Richard Northcott’s responsibilities to include Head of Business Development Strategy alongside Marine and Energy. These changes follow a quarter in which Hamilton reported a 27.7% year-on-year revenue increase and the largest analyst...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Why uniQure (QURE) Is Up 59.1% After FDA Oversight Shift and AMT-130 Analyst Upgrades – And What's Next

In early March 2026, uniQure reported full-year 2025 results showing revenue of US$16.1 million and a net loss of US$198.97 million, while also facing multiple securities class action lawsuits over alleged misstatements about FDA interactions for its AMT-130 Huntington’s disease gene therapy. At the same time, sentiment around uniQure has shifted as several banks upgraded the stock after news that the FDA official overseeing AMT-130 will step down, raising questions about how a possible...
NasdaqGS:ENVX
NasdaqGS:ENVXElectrical

Is Enovix (ENVX) Starting To Look Interesting After Recent Share Price Slide?

If you are wondering whether Enovix at around US$4.92 is starting to look interesting or still too risky for your portfolio, this article will help you size up what you are really paying for. The share price has been under pressure, with returns of a 2.6% decline over 7 days, 21.7% decline over 30 days, 37.6% decline year to date, 31.8% decline over 1 year, 54.7% decline over 3 years and 67.4% decline over 5 years. Recent coverage has focused on Enovix's position in advanced battery...
NasdaqGS:CCB
NasdaqGS:CCBBanks

Does Board Expansion and Fintech Hire Reshape the Bull Case for Coastal Financial’s BaaS Strategy (CCB)?

Coastal Financial Corporation recently expanded its Board of Directors to twelve members by appointing fintech veteran Jeffrey M. Chapman, who will serve on the Technology Committee and the CCBX Oversight Committee, reinforcing its focus on technology governance and digital banking innovation. This board appointment comes alongside reports of very large multi‑year net interest income growth, a strong 7.1% net interest margin, and outperformance in earnings per share growth versus peers,...
NYSE:PCOR
NYSE:PCORSoftware

A Look At Procore Technologies (PCOR) Valuation After New CFO And CRO Appointments

Procore Technologies (PCOR) has put fresh leadership at the center of its story, with Rachel Pyles stepping in as CFO and Walt Hearn as CRO on April 1, 2026, while outgoing leaders shift into advisory roles. See our latest analysis for Procore Technologies. Those leadership appointments come as Procore’s share price, now at US$57.03, reflects mixed momentum, with a 30 day share price return of 8.73% set against a 90 day share price return decline of 23.40% and a 1 year total shareholder...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

A Look At SIGA Technologies (SIGA) Valuation After 2025 Earnings, New TPOXX Orders And Funding

SIGA Technologies (SIGA) is back in focus after its 2025 earnings showed lower year over year revenue and net income, alongside fresh government funding, new international TPOXX orders, and pending European regulatory decisions. See our latest analysis for SIGA Technologies. The share price has come under pressure around the earnings release, with a 7 day share price return of 12.34% and a 30 day share price return of an 18.24% decline, even though the 1 year total shareholder return is...
NYSE:TAP
NYSE:TAPBeverage

Molson Coors Taps Simply Spiked Bolder To Support Growth Story

Molson Coors Beverage (NYSE:TAP) has introduced Simply Spiked Bolder, a new 12% ABV flavored alcoholic drink under its partnership with Coca-Cola. The product expands the existing Simply Spiked line with a higher-strength, portable option aimed at the high-ABV flavored alcoholic drinks segment. The launch comes as the company addresses volume and profit pressures and looks to refine its product mix. For you as an investor, Simply Spiked Bolder sits at the intersection of two important...
NasdaqGS:REYN
NasdaqGS:REYNHousehold Products

Reynolds Consumer Products Weighs Product Upgrades As Demand Stays Soft

Reynolds Consumer Products is facing ongoing weak demand, with unit sales declining for two consecutive years. The company may need to invest in new product improvements to address softer demand across its core categories. These trends raise questions about how Reynolds Consumer Products, traded as NasdaqGS:REYN, will respond to protect its position in household goods. Reynolds Consumer Products, the company behind many everyday kitchen and household items, is under pressure as unit sales...
NasdaqGS:MSEX
NasdaqGS:MSEXWater Utilities

Assessing Middlesex Water (MSEX) Valuation After Recent Mixed Shareholder Returns

Middlesex Water (MSEX) has been drawing fresh attention after recent trading left the shares around $51.94, with returns mixed over the past month, past 3 months and year. This has prompted closer scrutiny of its regulated utility profile. See our latest analysis for Middlesex Water. Recent trading presents a mixed picture, with a 1-day share price return of 1.07% but a 1-year total shareholder return decline of 13.42%. This suggests that recent momentum remains tentative following a weaker...
NYSE:IRM
NYSE:IRMSpecialized REITs

A Look At Iron Mountain (IRM) Valuation After Strong Three Year Total Return Performance

Why Iron Mountain is on investors’ radar Iron Mountain (IRM) has been drawing attention after a period of strong total returns over the past 3 years, prompting investors to reassess how its recent performance lines up with current valuation. See our latest analysis for Iron Mountain. At a share price of US$107.38, Iron Mountain’s short term momentum has cooled slightly after strong gains. A 30 day share price return of 8.13% and a 3 year total shareholder return of 126.63% suggest earlier...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

Gaming And Leisure Properties Refinancing Draws Focus To Valuation Gap

Gaming and Leisure Properties, NasdaqGS:GLPI, has arranged a new $679 million term loan under an amended credit agreement. The company has fully repaid and terminated a prior term loan facility as part of this refinancing move. This refinancing aligns with management's efforts to manage the capital structure and extend debt maturities. For investors watching Gaming and Leisure Properties, the refinancing comes with the stock trading at $48.36 and a multi year return of 57.2% over the past 5...
NYSE:EVR
NYSE:EVRCapital Markets

Evercore Expands Biotech ECM And Private Credit Advisory Fee Pools

Evercore (NYSE:EVR) has hired David Ke from J.P. Morgan as a senior managing director to lead its biotechnology equity capital markets effort. The firm has also been appointed to advise a $1 billion private credit secondary transaction for the Cliffwater Corporate Lending Fund. For investors watching NYSE:EVR, these moves touch two active parts of investment banking: biotechnology equity issuance and private credit secondaries. Evercore is known for advisory and capital markets work, and...
NYSE:VTR
NYSE:VTRHealth Care REITs

Is It Too Late To Consider Ventas (VTR) After Its Strong Multi Year Share Price Run?

Wondering if Ventas at around US$86.20 is still offering fair value, or if the easy money has already been made? This article breaks down what the current price might be implying. With the share price at US$86.20 and returns of 1.5% over 7 days, 2.7% over 30 days, 11.5% year to date, 33.6% over 1 year, 107.2% over 3 years and 85.8% over 5 years, many investors are asking whether the recent performance has already priced in the key positives or shifted the risk profile. Recent coverage around...
NYSE:KWR
NYSE:KWRChemicals

Is Quaker Chemical (KWR) Now Pricing In Too Much Pessimism After Recent Share Slump

If you are looking at Quaker Chemical and asking whether the current share price lines up with its underlying value, this article will walk through the numbers in a clear and practical way. The stock most recently closed at US$120.92, after returns of a 10.6% decline over 7 days, a 31.3% decline over 30 days, a 13.0% decline year to date, a 5.8% decline over 1 year, a 31.9% decline over 3 years, and a 47.8% decline over 5 years. These moves have kept Quaker Chemical on the radar for...
NasdaqGS:WLTH
NasdaqGS:WLTHCapital Markets

Wealthfront (WLTH) Valuation After 40% Year To Date Share Price Slide

If you are wondering whether Wealthfront's current share price matches its underlying worth, you are not alone. This article will focus squarely on how the stock lines up against a range of valuation checks. Wealthfront shares last closed at US$7.88, with a return of a 10.4% decline over the past 7 days and a 3.9% decline over the past 30 days, while the year-to-date return stands at a 40.4% decline. Recent coverage around Wealthfront has focused on its position within diversified financials...
NYSE:WHR
NYSE:WHRConsumer Durables

Is Whirlpool (WHR) Now Offering An Opportunity After Steep Share Price Declines?

If you are wondering whether Whirlpool's share price now reflects fair value, this article will walk through what the current market price might be implying about the business. Whirlpool's stock has recently faced heavy pressure, with returns of a 6.7% decline over the past week, a 37.3% decline over the past month, and a 31.7% decline over the last year, alongside longer term 47.0% and 65.7% declines over 3 and 5 years. These price moves sit against a backdrop where investors continue to...